UNIVERSITY OF DUNDEE AND CORBIN THERAPEUTICS ENTER INTO COLLABORATION AGREEMENT TO DISCOVER NOVEL UBIQUITIN-SPECIFIC PROTEASE INHIBITORS

Dundee, Scotland UK and Montreal, Québec, Canada, May 22, 2017 – University of Dundee, its Drug Discovery Unit (“DDU”), and Corbin Therapeutics (“Corbin”) are pleased to announce their collaboration agreement to screen and identify small molecules capable of efficiently inhibiting a well-conserved ubiquitin-specific protease, USP15. Corbin focuses on a novel therapeutic approach to treat various[…]